reverse transcriptase m-mul v

Features

  • Pure reverse transcriptase for cDNA synthesis
  • High yields of first-strand cDNA
  • High value for a fair price

Applications

  • First-strand cDNA synthesis
  • Generation of labeled cDNA
  • RNA analysis by primer extension

 Product Description

biotechrabbit MMuLV Reverse Transcriptase is an exceptionally pure DNA polymerase which uses RNA as a substrate and exhibits no measurable proofreading 3’→5′ exonuclease function. This enzyme performs cDNA synthesis by extending a DNA primer annealed to an RNA template; it can also make copies from a single-stranded DNA templates.

The enzyme is purified from a recombinant E. coli strain carrying the MMuLV reverse transcriptase gene.

 

 

Component

Composition

MMuLV Reverse Transcriptase

MMuLV Reverse Transcriptase, 200 U/µl, in storage buffer containing 50% (v/v) glycerol.

10× MMuLV RT Buffer

Optimized 10× MMuLV Reverse Transcriptase reaction buffer.

 

STORAGE

-20°C (until expiry date – see product label)

Unit Definition

One unit is the amount of enzyme activity that incorporates 1 nmole of dTTP into acid insoluble fraction in 10 minutes at 42°C when poly(A)+ RNA and oligo (dT)20 are used as template-primer.

Quality Control
Functional Assay

cDNA synthesis with specific primers, followed by quantitative PCR.

Exonuclease assay

Linearized lambda/HindII fragments are incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.

Endonuclease assay

lambda DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.

Nick Activity

Supercoiled plasmid DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No conversion of covalently closed circular DNA to nicked DNA was detected.

E. coli genomic DNA contamination assay

A sample of Reverse Transcriptase is analyzed with specific primers targeting the 16S rRNA gene in qPCR for the presence of contaminating E. coli DNA. No E. coli DNA was detectable.

RNase Assay

A sample of the enzyme was incubated with a RNA template. RNase activity was not observed after agarose gel electrophoresis.

 

reverse transcriptase m-mul v
reverse transcriptase m-mul v
Prevention of cDNA synthesis reaction contamination

RNase contamination is an exceptional concern when working with RNA. RNase A, providing most threat to RNA integrity, is a highly stable contaminant of any laboratory. To prevent RNA from degradation and to minimize possibility of contamination during cDNA synthesis; follow the guidelines below:

  • Use separate clean areas for preparation of the samples and the reaction mixture.
  • DEPC-treat all tubes and pipette tips or use certified nuclease-free labware with aerosol filters.
  • Wear fresh gloves when handling RNA and all reagents.
  • Always assess the integrity of RNA prior to cDNA synthesis in denaturing agarose gel electrophoresis.
  • Use RNase free water and other reagents.
  • To prevent RNA from degradation, add Ribonuclease inhibitor (optional) in to the cDNA synthesis reaction (20 units for 20 µl reaction).
Typical cDNA synthesis reaction set up
  • Thaw on ice and mix very well all reagents.
  • Assemble and keep all reactions on ice.
  • To use time and reagents effectively, always prepare master mix for multiple reactions. For a master mix volume, always calculate the number reactions that you need plus one additional.
  • Combine the following in an RNase-free reaction tube:

Component

Volume

Final concentration

dNTP Mix (10 mM each dNTP)

4 µl

2 mM (each dNTP)

RNase Inhibitor, 40 U/µl (optional)

1 µl

2 U/µl

Oligo (dT)12–18 (10 µM) – or

Hexamer Primer (25 µM) – or

Gene Specific Primer (10 µM)

0.5 µl

1 µl

0.5 µl

0.25 µM

1.25 µM

0.25 µM

10× MMuLV RT Buffer

2 µl

RNA Template

0.5–5 µg total RNA or

50–500 ng mRNA (polyA)

MMuLV Reverse Transcriptase

1 µl

10 U/µl

RNase-free water

Variable

Total volume

20 µl

  • Mix and collect the drops by centrifuging briefly.
  • When using
    • Hexamer Primer, incubate 10 minutes at 25°C followed by 42°C for 45–60 minutes
    • Oligo (dT) or gene-specific Primer incubate at 42°C for 45–60 minutes.
  • Inactivate enzyme at 85°C for 10 minutes.
  • Collect the drops by spinning briefly.
  • Store products at –20°C or proceed to next step, like PCR or qPCR.
  • Use maximum 10 µl of the cDNA synthesis reaction mix for PCR in 50 µl volume.

 

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)

abx411284-100g 100 µg
EUR 425

Anti-BTLA Neutralizing Antibody

100244 100 µg
EUR 355
Description: This anti-BTLA antibody is a purified recombinant human monoclonal antibody which recognizes the human BTLA protein. BTLA (B- and T-lymphocyte attenuator) belongs to the CD28 immunoglobulin superfamily (IgSF) and is an immune-regulatory receptor that binds to HVEM (Herpesvirus entry mediator, also known as TNFRSF14, Tumor necrosis factor receptor superfamily member 14). This antibody has been tested for specific binding to purified human BTLA protein and neutralizes the interaction between BTLA and HVEM.

Anti-VEGF Neutralizing Antibody

79478-1 50 µg
EUR 355
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.

Anti-VEGF Neutralizing Antibody

79478-2 100 g
EUR 460
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species.

Anti-LAG3, Neutralizing Antibody

71219 100 µg
EUR 530
Description: Neutralizing recombinant human antibody recognizing the Lag-3 binding region.

Anti-VISTA Neutralizing Antibody

101293 100 µg
EUR 450
Description: This human monoclonal antibody recognizes human V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA), and neutralizes its interaction with VSIG3 (also called IGSF11). VISTA is also known as B7-H5 or VSIR (GenBank Accession No. NM_022153). VSIG3 is a ligand involved in cell adhesion as a VISTA binding partner. This neutralizing antibody has been functionally tested using the VSIG-3:VISTA [Biotinylated] Inhibitor Screening Assay Kit (BPS Bioscience #79782).

Anti-RANKL Neutralizing Antibody

100874-1 50 µg
EUR 335
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Anti-RANKL Neutralizing Antibody

100874-2 100 µg
EUR 460
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain).

Anti-PCSK9 Neutralizing Antibody

71207 50 µg
EUR 555
Description: Neutralizing recombinant human antibody (IgG1) recognizing the LDLR binding region of human PCSK9.

Anti-TIGIT Neutralizing Antibody

71340 100 µg
EUR 565
Description: Human Anti-TIGIT neutralizing antibody recognizing the TIGIT binding region on immune cells.

Anti-PD-1 Neutralizing Antibody

71120 100 µg
EUR 465
Description: Neutralizing recombinant murine/human chimeric antibody recognizing the PD-L1/PD-L2 binding region of human PD-1. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species.

Interferon alpha Neutralizing Antibody

20-abx137013
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-IL-17A Neutralizing Antibody

91015 100 µg
EUR 490
Description: Neutralizing recombinant human_x000D_chimeric antibody recognizing human IL-17A._x000D_This antibody has not been tested for crossreactivity_x000D_with other species.

Anti-β-Amyloid Neutralizing Antibody

71223 100 µg
EUR 465
Description: Purified, recombinant, humanized Anti-β-amyloid (IgG1) antibody, expressed in HEK293 cells. This antibody reacts with human β-amyloid and has not been tested for cross-reactivity with other species.

Anti-CTLA4 (CD152) Neutralizing Antibody

71212 100 µg
EUR 490
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species.

Enterovirus 71 VP4 Neutralizing Antibody

abx201328-100l 100 µl
EUR 350

Enterovirus 71 VP4 Neutralizing Antibody

abx201328-50l 50 µl
EUR 275

Denosumab Neutralizing Antibody ELISA Kit

abx395211-50g 50 µg
EUR 1937.5

Anti- Interferon Beta Neutralizing Antibody

GWB-C275F9 0.1 mg Ask for price

Anti-PD-L1 (CD274) Neutralizing Antibody

71213 100 µg
EUR 505
Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested.

Interferon Beta Human Neutralizing, Antibody

GWB-A7C102 0.5 mg Ask for price

SARS-CoV-2 Spike Neutralizing Antibody

abx229977-100g 100 µg
EUR 325

SARS-CoV-2 Spike Neutralizing Antibody

abx229978-100g 100 µg
EUR 325

SARS-CoV-2 Spike Neutralizing Antibody

abx229979-100g 100 µg
EUR 325

SARS-CoV-2 Spike Neutralizing Antibody

abx229980-100g 100 µg
EUR 425

SARS-CoV-2 Spike Neutralizing Antibody

abx229981-100g 100 µg
EUR 425

SARS-CoV-2 Spike Neutralizing Antibody

abx229982-100g 100 µg
EUR 325

SARS-CoV-2 Spike Neutralizing Antibody

abx229983-100g 100 µg
EUR 325

Anti-2019-nCoV Spike Neutralizing Antibody

E-AB-V1024-100uL 100uL
EUR 650
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

E-AB-V1024-50uL 50uL
EUR 390
Description: Unconjugated

Anti-2019-nCoV Spike Neutralizing Antibody

E-AB-V1024-each each Ask for price
Description: Unconjugated

Leave a Comment